Study compares data from hundreds of people in childhood and old age
A new study shows compelling evidence that associations between cognitive ability and cortical grey matter in old age can largely be accounted for by cognitive ability in childhood. The joint study by the Montreal Neurological Institute and Hospital, The Neuro, McGill University and the University of Edinburgh, UK was published today, June 4 in
The McGill Centre for Studies in Aging and the Douglas Brain Imaging Centre would like to invite you to the following:
Morning Symposium on Cognitive Neuroscience of Aging
“Past & Future: Remembering and Imagining in Young and Older Adults”
Donna Rose Addis, PhD (University of Auckland, New Zealand)
“False Memories and Aging”
Nancy Dennis, PhD (Pennsylvania State University)
Coffee and pastries will be served at the sy
Dr. Robert J.
Live 3D images of brain’s vasculature will improve patient diagnosis and treatment
The diagnosis and treatment of potentially life-threatening neurological conditions such as aneurysms and strokes will be significantly improved as a result of cutting-edge technology at the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the MUHC. The new angiosuite, inaugurated today, offers significant advantages to patients and physicians including most importantly, improved safety and outcomes.
- Creates a 3D “
New study shows what happens in the brain to make music rewarding
A new study reveals what happens in our brain when we decide to purchase a piece of music when we hear it for the first time. The study, conducted at the Montreal Neurological Institute and Hospital – The Neuro, McGill University and published in the journal Science on April 12, pinpoints the specific brain activity that makes new music rewarding and predicts the decision to purchase music.
What is Parkinson’s Disease?
Parkinson’s disease is a neurological condition related to the death of specific brain cells that produce dopamine, a chemical needed for brain cells to control muscular movement. In Parkinson’s disease, dopamine-producing cells stop functioning for reasons still unknown.
Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease
A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation (BMT) has positive results in patients with particularly aggressive forms of MS. The transplantation treatment, which is performed as part of a clinical trial and carries potentially serious risks, virtually stops all new relapsing activity as observed upon clinical examination and brain MRI scans. The study reveals how th
Post-Synaptic Careers - Life after a Neuroscience Degree (A new Discussion Series with guest speakers)
What can one do after a degree in Neuroscience?
This discussion series will address this question through informal conversations with some successful non-academics with graduate degrees in neuroscience; the series will compliment IPN’s Pathways and Connections, which is the academic equivalent of Post-Synaptic Careers. This is your chance to talk to those who were once where you are. Ask the guest speakers about the often difficult decision to leave academia and the important, but sometimes serendipitous, connections that led them to where they are now.
A team of basic and clinical scientists led by the University of Montreal Hospital* Research Centre’s (CRCHUM) Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis (MS).
March - National Epilepsy Awareness Month
The Neuro has been at the forefront of epilepsy treatment and research for over half a century. The development of “The Montreal Procedure” by Dr.